好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Vitamin D Assessment in Veterans with Parkinson’s Disease
Movement Disorders
P5 - Poster Session 5 (5:30 PM-6:30 PM)
10-046

To determine vitamin D testing use, deficiency treatment and follow-up among a group of Veterans with PD.

Interest in vitamin D deficiency and its consequences is increasing.  Within the Veterans Health Administration, use of vitamin D testing increased from 1.2% in fiscal year 2007 to 14.9% in fiscal year 2012. Vitamin D deficiency is more prevalent in Parkinson’s disease (PD) as compared to healthy controls and patients with Alzheimer’s dementia. Despite previous reports of vitamin D deficiency in PD, estimation of vitamin D levels is not routinely done.

Queries were run to find the total number of PD patients seen in the Houston’s Parkinson’s Disease Research, 好色先生 and Clinical Center (PADRECC) from 10/01/2001 to 03/31/2018, whether they received vitamin D testing, and whether those with deficiency received medication and follow-up vitamin D testing.
586 out of 2005 PD patients (29%) had vitamin D levels estimated.  300 patients (51%) had vitamin D levels below 30ng/ml, while 286 patients (49%) had levels above 30ng/ml. 216 patients (72%) with low levels of vitamin D received vitamin D replacement therapy while 84 patients (28%) were untreated. 112 patients out of 300 (37%) with low levels did not had follow up vitamin D level assessment. Out of 188 patients who had follow up level checked, 105 (56%) still had vitamin D level below 30ng/ml and 83 patients (44%) had levels above 30ng/ml.

Although vitamin D assessment has been increasing, close monitoring and treatment of low vitamin D level in PD patients is sub-optimal.


Authors/Disclosures
Fariha Jamal
PRESENTER 		No disclosure on file
George R. Jackson, MD, PhD (MEDVAMC) Dr. Jackson has nothing to disclose.
No disclosure on file
Aliya Sarwar, MD (Baylor College of Medicine/ MEDVAMC) Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.